Gary Gurka, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 63 Mass Ave, Arlington, MA 02474 Phone: 781-648-2540 Fax: 781-641-9844 |
Dr. David H. Sachs, M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Not Enrolled in Medicare Practice Location: Bldg. 149-9019, 13th Street, Boston, MA 02466 Phone: 617-726-4065 Fax: 617-726-4067 |
Dr. Anne Esther Goldfeld, M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Not Enrolled in Medicare Practice Location: 800 Huntington Ave, Boston, MA 02115 Phone: 617-278-3351 Fax: 617-278-3454 |
Dr. Sachin Niranjan Baxi, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 6, Boston, MA 02115 Phone: 617-919-2489 Fax: 617-730-0310 |
Dr. Richard Arthur Moscicki, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 15 Parkman St, Allergy Associates Wac 626, Boston, MA 02114 Phone: 617-726-3764 Fax: 617-252-7694 |
Abduarahmn Almutairi, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 |
John L Ohman, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 750 Washington St, Nemc Box 30, Boston, MA 02111 Phone: 617-636-5000 Fax: 617-636-4843 |
Dr. Paul J. Maglione, MD, PHD Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 9 Suite B, Boston, MA 02118 Phone: 617-638-7480 |
Wayne A Marasco, M.D., PH.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 44 Binney St, Jfb 824, Boston, MA 02115 Phone: 617-632-2153 |
Dr. Jeffrey A Gelfand, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, S50-801 Infectious Disease Associates, Boston, MA 02114 Phone: 617-726-1796 |
Dr. Lynda G Kabbash, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-726-3850 |
Alanna Wong, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8 Hawthorne Pl, Ste 104, Boston, MA 02114 Phone: 617-742-5730 |
Dr. Dinah Foer, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 |
Nancy I Joseph, DO Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 75 State St Fl 26, Boston, MA 02109 Phone: 617-204-3500 |
Dr. Hans C Oettgen, MD, PHD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 |
Dr. Christina Cruz, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Boston, MA 02111 Phone: 617-636-5000 |
Fayhan Alroqi, M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 202-751-7894 |
Dr. William Sheehan, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 6; Division Of Immunology, Boston, MA 02115 Phone: 617-355-6117 |
Jessica Dickey Gereige, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 725 Albany St Ste 9b, Boston, MA 02118 Phone: 617-638-7460 Fax: 617-638-7486 |
Dr. Kurt Julius Bloch, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit St, Bul 422, Boston, MA 02114 Phone: 617-724-9540 Fax: 617-726-5806 |
News Archive
Eli Lilly and Company has announced that it will be extending its existing patient assistance program, LillyAnswers, through the end of this year to qualifying patients currently participating in the program, to help bridge the gap in coverage for people who need Lilly medicines, but are not yet enrolled in Medicare Part D.
Increased uptake of plant-based diets in New Zealand could substantially reduce greenhouse gas emissions while greatly improving population health and saving the healthcare system billions of dollars in the coming decades, according to a new University of Otago study.
OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, received approval from the European Commission for Tarceva as a monotherapy maintenance treatment in patients with advanced non-small cell lung cancer (NSCLC) whose disease remains largely unchanged (stable disease) after platinum-based initial chemotherapy.
An analysis of healthcare data in Ontario, Canada found a significant decline in referrals and procedures performed for common cardiac interventions after the onset of the COVID-19 pandemic.
› Verified 2 days ago